Mental health technology
Digital reach.
Human relevance.
JAAQ combines mental health content and digital engagement with a clinically governed approach, serving organisations that want to connect people with information and support.
2026
through Bupa
August 2026
Management-reported figures, August 2026. A separate public March 2026 announcement reports $17m in funding; these amounts are not added together. Reach is not a measure of active use or clinical outcomes. Contracted revenue is distinct from revenue recognised and cash received.
Meeting people
where they are.
JAAQ’s business model focuses on organisational relationships and digital delivery. Its reported customers include Bupa, NatWest, Nationwide and Workday.
For investors, the opportunity is to understand how those relationships translate into sustained engagement, renewals and expansion. JAAQ reported 100% net revenue retention in August 2026, a figure to assess alongside its measurement period and customer base.
The commercial opportunity
- Deepening existing employer and insurer relationships.
- Extending digital access across markets and customer populations.
- Combining engaging content with appropriate clinical governance.
Leadership and backing
Experience across
technology and health.
Led by CEO Alex Packham, JAAQ has board members and backers with experience across business, healthcare and venture investing, including Simon Morris, Paul Thandi, Guinness Ventures, Meridian Health Ventures and Fuel Ventures.
Steve Bolton serves as an Investor Director. Bolt reports supporting the finance function during the seed stages and helping appoint the CEO.
Progress to follow.
Evidence to review.
Expansion and customer adoption
JAAQ’s expansion priorities include international rollout through Bupa and additional customer relationships. Delivery and adoption remain key measures of progress.
Clinical development
As at August 2026, an NHS Trust clinical validation programme and Class I medical device certification work were in progress.
Investor diligence
Review renewal economics, engagement, customer concentration, clinical governance and the capital needed for expansion.
